 | • レポートコード：MRC2203A147 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の細胞増殖市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（消耗品、試薬・培地・血清、使い捨て用品、機器）分析、細胞種類別（ヒト細胞、動物細胞）分析、用途別（再生医療・幹細胞研究、癌・細胞ベース研究、その他）分析、エンドユーザー別（バイオテクノロジー・バイオ医薬品企業、研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の細胞増殖市場規模：製品別（消耗品、試薬・培地・血清、使い捨て用品、機器） ・世界の細胞増殖市場規模：細胞種類別（ヒト細胞、動物細胞） ・世界の細胞増殖市場規模：用途別（再生医療・幹細胞研究、癌・細胞ベース研究、その他） ・世界の細胞増殖市場規模：エンドユーザー別（バイオテクノロジー・バイオ医薬品企業、研究機関、その他） ・世界の細胞増殖市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Thermo Fisher Scientific, Inc.、Becton, Dickinson and Company、Terumo BCT、…） ・市場機会・将来傾向 |
The cell expansion market will show rapid growth due to the increasing incidence of chronic diseases, government investments for cell-based research and increasing focus on R&D for cell-based therapies.
The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the cell expansion market. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. According to the WHO, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths.
There is an increase in the prevalence of cancer patients that results in a large patient pool, which creates an opportunity for the manufacturers to tap and capitalize on the market. Hence there is an increase in the cases of chronic diseases that are expected to drive the overall market. Furthermore, technological advances in cell expansion devices and growth in government investments regarding healthcare issues are the factors propelling the market.
Key Market Trends
Consumables is Expected to be the Largest Growing Segment in the Cell Expansion Market
The consumables segment has been accounted for the largest share of the market and this is mainly due to the high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutical companies. There is also a constant requirement for new reagents among end-users that helps in market growth. Furthermore, the rising awareness regarding advanced treatment therapies such as personalized medicine is also another driving factor for this segment.
North America is Found Leading the Cell Expansion Market
The increasing incidences of chronic and cell-based diseases and rising geriatric population are the key factors driving the overall market in this region. The rising investment made by the companies as well as the government for cell expansion research is also a factor driving the market in this region.
The Asia Pacific is poised to grow owing to rapidly expanding biotechnology and biopharmaceutical industries, increasing government investments for cancer and stem cell research and rising focus of prominent players on the emerging markets.
Competitive Landscape
There has been a presence of a considerable number of companies that are mainly focusing on agreements and expansions to strengthen its business operations. There are various established business players that are adopting numerous organic and inorganic growth strategies to increase their market share. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Chronic Diseases
4.2.2 Government Investments for Cell-Based Research
4.2.3 Increasing Focus on R&D for Cell-Based Therapies
4.3 Market Restraints
4.3.1 Ethical Concerns Regarding Research in Cell Biology
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Consumables
5.1.2 Reagents, Media, & Serum
5.1.3 Disposables
5.1.4 Instruments
5.1.4.1 Cell Expansion Supporting Equipment
5.1.4.2 Bioreactors
5.1.4.3 Automated Cell Expansion Systems
5.2 By Cell Type
5.2.1 Human Cells
5.2.2 Animal Cells
5.3 By Application
5.3.1 Regenerative Medicine and Stem Cell Research
5.3.2 Cancer and Cell-Based Research
5.3.3 Other Applications
5.4 By End User
5.4.1 Biotechnology & Biopharmaceutical Companies
5.4.2 Research Institutes
5.4.3 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific, Inc.
6.1.2 Becton, Dickinson and Company
6.1.3 Terumo BCT
6.1.4 Merck KGaA
6.1.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
6.1.6 Miltenyi Biotec
6.1.7 Lonza Group LTD.
6.1.8 Stemcell Technologies, Inc.
6.1.9 GE Healthcare
6.1.10 Takara Bio Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS